Asset Details
Do you wish to reserve the book?
ADME of Bromo-DragonFLY as an example of a new psychoactive substance (NPS) – application of in Silico methods for prediction: absorption, distribution, metabolism and excretion
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
ADME of Bromo-DragonFLY as an example of a new psychoactive substance (NPS) – application of in Silico methods for prediction: absorption, distribution, metabolism and excretion
Do you wish to request the book?
ADME of Bromo-DragonFLY as an example of a new psychoactive substance (NPS) – application of in Silico methods for prediction: absorption, distribution, metabolism and excretion
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
ADME of Bromo-DragonFLY as an example of a new psychoactive substance (NPS) – application of in Silico methods for prediction: absorption, distribution, metabolism and excretion
2025
Overview
Bromo-DragonFLY, a new psychoactive substance (NPS) within the phenethylamine class, is noted for its exceptional potency and prolonged psychoactive effects. Despite its severe toxic reactions and fatalities, research on its human metabolic fate remains limited. This study predicts the absorption, distribution, metabolism, and excretion (ADME) of Bromo-DragonFLY using in silico methods. Results indicate high gastrointestinal absorption and potential blood-brain barrier penetration, enhancing its central nervous system effects. The compound shows significant plasma protein binding and involves multiple cytochrome P450 isoenzymes in its metabolism, with variability in phase I and II reactions. Predicted metabolites form through epoxidation, quinone formation, UGT conjugation, and N-dealkylation, exhibiting reactivity with proteins, DNA, and glutathione, contributing to its toxicological profile. Excretion is predicted mainly via renal pathways. These insights are crucial for understanding the toxicological risks of Bromo-DragonFLY, exemplifying the challenges posed by NPS.
Publisher
Nature Publishing Group UK,Nature Portfolio
